{"id":"W4410382863","doi":"10.1136/thorax-2024-222488","title":"Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial","year":2025,"lang":"en","type":"article","venue":"Thorax","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; University of Toronto; University of British Columbia; McGill University; Université Laval; University of Alberta; Université de Sherbrooke","funders":"Health Research Council of New Zealand; National Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; National Health and Medical Research Council; Swedish Orphan Biovitrum; Université Pierre et Marie Curie; Minderoo Foundation; NIHR Imperial Biomedical Research Centre; ZonMw; Sanofi; European Commission; Department of Health and Social Care; National University Health System; Translational Breast Cancer Research Consortium; Wellcome Trust; National Institute for Health and Care Research","keywords":"Medicine; Anakinra; Tocilizumab; Coronavirus disease 2019 (COVID-19); Critically ill; 2019-20 coronavirus outbreak; Intensive care medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Virology; Outbreak; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005861267,0.001652474,0.002442389,0.0002670942,0.0003578391,0.001308484,0.0007888892,0.001654822,0.003794413],"category_scores_gemma":[0.00540937,0.0005780146,0.002049285,0.0004043876,0.001383795,0.001203441,0.0007132071,0.002092084,0.0004327915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009693751,"about_ca_system_score_gemma":0.001361306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007271279,"about_ca_topic_score_gemma":0.0008501318,"domain_scores_codex":[0.9968063,0.002322791,0.0001689987,0.0003410927,0.00016496,0.0001959073],"domain_scores_gemma":[0.9972042,0.001172703,0.000736086,0.0002504762,0.000147276,0.0004892203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9863598,0.002289187,0.001060947,0.0003953252,0.0008988837,0.00002319891,0.00004086442,0.0003918343,0.0006476464,0.000136585,0.0002378845,0.007517832],"study_design_scores_gemma":[0.9643494,0.03300118,0.001175311,0.00004077579,0.0004154364,0.00001551006,0.00001347704,0.000456728,0.0001425673,0.0001611255,0.000217951,0.00001053179],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909084,0.002800353,0.0006591414,0.0005695329,0.000301686,0.003264473,0.0005299866,0.00003097185,0.0009353148],"genre_scores_gemma":[0.98959,0.00114004,0.00197221,0.0004899309,0.0004071101,0.004993221,0.0005855283,0.00001016411,0.0008117488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005861267,"threshold_uncertainty_score":0.03099769,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07397534580767474,"score_gpt":0.4419939990055278,"score_spread":0.3680186531978531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}